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THE MECHANISMS OF ANKLE STABILIZATION: THE 
ROLE OF ARTICULAR SURFACE GEOMETRY AS THE 
PRIMARY RESTRAINT 
Y Tochigi, MJ Rudert, CL Saltzman, A Amendola, TD Brown 
Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA 
Background: Severe intra-articular fractures frequently result 
in alteration of ankle geometry (i.e. surface incongruity and/or 
malalignment), leading to post-traumatic osteoarthritis. Despite 
the substantial dependency of passive ankle stability on articular 
surface geometry previously demonstrated in the literature, the 
mechanisms of ankle stabilization by articular surface resistance 
have not yet been well examined. This study hypothesized that 
articular surface resistance to non-axial loads and moments in- 
volves specific changes of cartilage contact stress that explain 
the contribution of articular surface geometry to passive ankle 
stability. 
Methods: Six cadaver ankles with all major peri-ankle ligaments 
intact were tested. Each specimen, held at several predeter- 
mined ankle positions under a primary 600N axial force, was 
subjected to various superimposed secondary loads (anterior/ 
posterior shear force, inversion/eversion torque, or internal/ex- 
ternal rotation torque). Each secondary load was applied inde- 
pendently, while allowing unconstrained motion associated with 
the two other secondary loading directions. Contact stress in 
the superior-inferior tibial-talar articular interface was monitored 
by a real-time contact stress transducer, and site-specific stress 
changes solely due to secondary loading at each load/position 
were determined. The role of these stress changes in ankle sta- 
bilization was studied for each specimen, by analyzing the data 
with a computer model of superior tibial-plafond surface geometry 
(Fig. 1). 
Results: Contact stress changes with every secondary load- 
ing modality were reproducible, regardless of ankle position. In 
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Fig. 1. Ankle geometric model with typical stress-change data• The superior 
tibial plafond geometry consists of two spherical sectors (radius = 25 mm, 
separation b/w centers = 20 mm). 
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Fig. 2. Relative contribution ofsurface resistance (n = 6). 
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the model analysis, the surface resistance associated with these 
stress changes was found to correlate linearly with the mag- 
nitude of the applied secondary load, evidencing the consis- 
tent contribution of articular surface restraint o ankle stabiliza- 
tion. The relative contribution of articular surface restraint, by the 
superior-inferior interface (without including the effect of the me- 
dial/lateral ankle "gutter" surfaces), was approximately 70% for 
the anterior/posterior forces, and 20-40% for the version and in- 
ternal/external rotation torques (Fig. 2). 
Discussion/Conclusions: Passive ankle stability under weight- 
bearing conditions appears to be substantially dictated by the ar- 
ticular surface geometry. Any abnormality that alters ankle geom- 
etry can impact ankle stability under weight-bearing conditions. 
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DIACERHEIN IS EFFECTIVE IN THE TREATMENT OF 
PAINFULL KNEE OA: RANDOMIZED, CONTROLLED 
STUDY 
K Pavelka, M Olejarova, J Rovensky 
Clinical Dept., Institute of Rheumatology, Prague 2, Czech 
Republic; Clinical Dept., Institute of Rheumatology, Prague 2, 
Czech Republic; Clinical Dept., Institute of Rheumatology, 
Piestany, Slovakia (Slovak Republic) 
Background: Diacerhein is IL-11~ inhibitor which has shown to in- 
fluence both catabolism and anabolism of chondrocytes in OA. It 
has documented both symptomatic and structure modifying prop- 
erties in some studies, but failed in others. 
Objectives: The aim of the study was to determine the efficacy 
and safety of a 3 month treatment with diacerhein (Artrodar) in 
reducing pain and improving function in the target joint of patients 
with painful knee OA and also estimate duration of the effect once 
the treatment was stopped (carry over effect). 
Methods: 
Patients: Tibiofemoral OA (ACR), pain > 40 mm on > 2 items 
of WOMAC. Radiologically II.-III. stage. Outcome measures: Pri- 
mary efficacy criterion was section A of WOMAC (0-100 mm) at 
week 24 (12 weeks after the stop of therapy). The secondary effi- 
cacy variables were: total WOMAC, patient and physician global, 
SF 36, paracetamol consumption and presence of effusion. 
Medication: Diacerhein 50 mg bid or placebo for 12 weeks, as 
rescue medication paracetamol up to 2 g daily, in post treatment 
period only paracetamol. 
Results: 168 patients (84 and 84) were included and 152 fin- 
ished (90,5%) - 75 in placebo groups and 77 in diacerhein group. 
There were no differences between the study groups at base- 
line (age, duration of disease, BM (and pain severity). The val- 
ues for WOMAC A decreased in both group compared to base- 
line at week 24, but the difference was in favour of diacerhein 
(p=0,0001). (ITT analysis). The difference between diacerhein 
and placebo were statistically significant from week 8-24. The 
similar effects were in WOMAC C function (p< 0,0001) and in 
majority of secondary outcome measures. The tolerance of diac- 
erhein was very good and no serious adverse events were re- 
ported. Diarrhoea was present at 11% of patients in diacerhein 
group, but leading to withdrawal only in 4,2%. 
Conclusion: This randomised, multicentre, double blind, placebo 
controlled study demonstrates carry-over effect of diacerhein in 
duration of 3 months. Diacerhein was more effective than placebo 
on pain on function from week 8 to week 12 (stop of treatment) to 
week 24. The tolerance of the drug was very good. Diacerhein is 
effective SYSADOA drug in knee OA. 
